"promis" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonMaxim Group Maintains ProMIS Neurosciences(PMN.US) With Buy Rating, Cuts Target Price to $35 - 富...
Maxim Group Maintains ProMIS Neurosciences(PMN.US) With Buy Rating, Cuts Target Price to $35 富途牛牛
Men's Basketball Signs Promis N'Landu to National Letter of Intent - George Washington University...
Men's Basketball Signs Promis N'Landu to National Letter of Intent George Washington University Athletics
Can ProMIS Neurosciences (NASDAQ:PMN) Afford To Invest In Growth? - Yahoo Finance
Can ProMIS Neurosciences (NASDAQ:PMN) Afford To Invest In Growth? Yahoo Finance
ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in...
ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease GlobeNewswire
ProMIS Neurosciences (PMN) Price Target Increased by 2,288.89% to 137.06 - Nasdaq
ProMIS Neurosciences (PMN) Price Target Increased by 2,288.89% to 137.06 Nasdaq
ProMIS Neurosciences regains Nasdaq compliance - MSN
ProMIS (NASDAQ: PMN) reports PMN310 Phase 1b >85% enrolled; interim data Q2 2026 - Stock Titan
ProMIS (NASDAQ: PMN) reports PMN310 Phase 1b >85% enrolled; interim data Q2 2026 Stock Titan
ProMIS Neurosciences completes enrollment for Alzheimer’s drug trial - Investing.com
ProMIS Neurosciences completes enrollment for Alzheimer’s drug trial Investing.com
Promis le ciel (Promised Sky), as seen by Erige Sehiri - Festival de Cannes
Promis le ciel (Promised Sky), as seen by Erige Sehiri Festival de Cannes
ProMIS Neurosciences Announces Reverse Stock Split - GlobeNewswire
ProMIS Neurosciences Announces Reverse Stock Split GlobeNewswire
HC Wainwright & Co. Reiterates ProMIS Neurosciences (PMN) Buy Recommendation - Nasdaq
HC Wainwright & Co. Reiterates ProMIS Neurosciences (PMN) Buy Recommendation Nasdaq
ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1...
ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310 Yahoo Finance
ProMIS Neurosciences Announces New Peer-Reviewed - GlobeNewswire
ProMIS Neurosciences Announces New Peer-Reviewed GlobeNewswire
Favourable Signals For ProMIS Neurosciences: Numerous Insiders Acquired Stock - Yahoo Finance
Favourable Signals For ProMIS Neurosciences: Numerous Insiders Acquired Stock Yahoo Finance
ProMIS Neurosciences Granted Fast Track Designation by U.S. - GlobeNewswire
ProMIS Neurosciences Granted Fast Track Designation by U.S. GlobeNewswire
ProMIS Neurosciences Announces $0.8 Million Registered Direct Offering, Priced At-the-Market Unde...
ProMIS Neurosciences Announces $0.8 Million Registered Direct Offering, Priced At-the-Market Under Nasdaq Rules Yahoo Finance
ProMIS Neurosciences Strengthens Board with Appointment of - GlobeNewswire
ProMIS Neurosciences Strengthens Board with Appointment of GlobeNewswire
ProMIS Neurosciences stock plunges after announcing 1-for-25 reverse split - Investing.com
ProMIS Neurosciences stock plunges after announcing 1-for-25 reverse split Investing.com
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference...
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference GlobeNewswire
ProMIS Neurosciences (Nasdaq: PMN) data support lower ARIA risk potential for PMN310 - Stock Titan
ProMIS Neurosciences (Nasdaq: PMN) data support lower ARIA risk potential for PMN310 Stock Titan
ProMIS Neurosciences shareholders approve share consolidation proposal - Investing.com
ProMIS Neurosciences shareholders approve share consolidation proposal Investing.com
ProMIS reports promising data for selective Alzheimer’s antibody - Investing.com
ProMIS reports promising data for selective Alzheimer’s antibody Investing.com
ProMIS Neurosciences Stock (PMN) Opinions on Alzheimer’s Candidate Fast Track Designation | PMN S...
ProMIS Neurosciences Stock (PMN) Opinions on Alzheimer’s Candidate Fast Track Designation | PMN Stock News Quiver Quantitative
Milbury Max a buys ProMis Neurosciences (PMN) shares worth $14928 - Investing.com
Milbury Max a buys ProMis Neurosciences (PMN) shares worth $14928 Investing.com
ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 .....
ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 ... Caledonian Record
ProMIS Neurosciences stock rises after promising Alzheimer’s research data - Investing.com
ProMIS Neurosciences stock rises after promising Alzheimer’s research data Investing.com
ProMIS Neurosciences stock price target lowered to $5 at Guggenheim - Investing.com
ProMIS Neurosciences stock price target lowered to $5 at Guggenheim Investing.com
ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a Predictive ...
ProMIS Neurosciences Announces $2.4 Million PIPE Financing for Clinical Development of PMN310 - N...
ProMIS Neurosciences Announces $2.4 Million PIPE Financing for Clinical Development of PMN310 Nasdaq
Maxim Group Initiates Coverage of ProMIS Neurosciences (PMN) with Buy Recommendation - Nasdaq
Maxim Group Initiates Coverage of ProMIS Neurosciences (PMN) with Buy Recommendation Nasdaq
ProMIS Neurosciences Announces Private Placement Financing - GlobeNewswire
ProMIS Neurosciences Announces Private Placement Financing GlobeNewswire
PMN Stock Price and Chart — NASDAQ:PMN - TradingView — Track All Markets
PMN Stock Price and Chart — NASDAQ:PMN TradingView — Track All Markets
Validation of the PROMIS Global Physical and Mental Health Scale for Gastrointestinal Disorders: ...
Validation of the PROMIS Global Physical and Mental Health Scale for Gastrointestinal Disorders: A Large-Scale Cross-Sectional Survey Wiley Online Library
ProMIS Neurosciences Approves Key Shareholder Proposals - TipRanks
ProMIS Neurosciences Approves Key Shareholder Proposals TipRanks
ProMIS Neurosciences (PMN) Completes Patient Enrollment for Alzh - GuruFocus
ProMIS Neurosciences (PMN) Completes Patient Enrollment for Alzh GuruFocus
ProMIS (Nasdaq: PMN) plans Nov 10 fireside chat in Boston; webcast available 30 days - Stock Titan
ProMIS (Nasdaq: PMN) plans Nov 10 fireside chat in Boston; webcast available 30 days Stock Titan
ProMIS Neurosciences completes enrollment for Alzheimer’s drug trial By Investing.com - Investing...
ProMIS Neurosciences completes enrollment for Alzheimer’s drug trial By Investing.com Investing.com South Africa
ProMIS Neurosciences receives extension from Nasdaq to regain minimum bid price - Investing.com
ProMIS Neurosciences receives extension from Nasdaq to regain minimum bid price Investing.com
FDA Fast-Tracks Revolutionary Alzheimer's Drug Promising Fewer Side Effects Than Current Treatmen...
FDA Fast-Tracks Revolutionary Alzheimer's Drug Promising Fewer Side Effects Than Current Treatments Stock Titan
ProMIS Neurosciences stock price surges in pre market trading as company receives FDA fast track ...
FDA grants fast track designation to ProMIS Neurosciences’ Alzheimer’s drug - Investing.com
FDA grants fast track designation to ProMIS Neurosciences’ Alzheimer’s drug Investing.com
Insider Scoop: Major Stock Purchase at ProMIS Neurosciences! - TipRanks
Insider Scoop: Major Stock Purchase at ProMIS Neurosciences! TipRanks
ProMIS Neurosciences files to sell 28.23M common shares for holders - MSN
ProMIS Neurosciences files to sell 28.23M common shares for holders MSN
ProMIS Neurosciences Q3 2025 Financial Results - TradingView — Track All Markets
ProMIS Neurosciences Q3 2025 Financial Results TradingView — Track All Markets
ProMIS Neurosciences exceeds target enrollment in PRECISE-AD - TipRanks
ProMIS Neurosciences exceeds target enrollment in PRECISE-AD TipRanks
ProMIS Neurosciences stock gets FDA Fast Track designation for PMN310 - Investing.com
ProMIS Neurosciences stock gets FDA Fast Track designation for PMN310 Investing.com
ProMIS Neurosciences shareholders approve share consolidation proposal - Investing.com
ProMIS Neurosciences shareholders approve share consolidation proposal Investing.com
Trump vows 'very serious retaliation' against ISIS after deadly Syrian ambush kills US soldiers -...
Trump vows 'very serious retaliation' against ISIS after deadly Syrian ambush kills US soldiers Fox News
ProMIS Neurosciences to execute 1-for-25 reverse stock split - MSN
ProMIS Neurosciences to execute 1-for-25 reverse stock split MSN
ProMIS Neurosciences exceeds target enrollment in Precise-AD phase 1b clinical trial - marketscre...
ProMIS Neurosciences exceeds target enrollment in Precise-AD phase 1b clinical trial marketscreener.com
ProMIS Secures $9.2M Funding Boost: Accelerates Novel Alzheimer's Treatment Development - Stock T...
ProMIS Secures $9.2M Funding Boost: Accelerates Novel Alzheimer's Treatment Development Stock Titan
Why Is ProMIS Neurosciences Stock (PMN) Up 180% Today? - TipRanks
Why Is ProMIS Neurosciences Stock (PMN) Up 180% Today? TipRanks
ProMIS Neurosciences (PMN) Reveals Promising Study Results for A - GuruFocus
ProMIS Neurosciences (PMN) Reveals Promising Study Results for A GuruFocus
ProMIS Neurosciences Advances Alzheimer’s Trial to Final Phase - TipRanks
ProMIS Neurosciences Advances Alzheimer’s Trial to Final Phase TipRanks
ProMIS Neurosciences Announces Reverse Stock Split - TipRanks
ProMIS Neurosciences: Stock Surge Insight - StocksToTrade
ProMIS Neurosciences: Stock Surge Insight StocksToTrade
ProMIS Neurosciences: Buy Rating Backed by Innovative EpiSelect™ Platform and Promising PMN310 Ca...
Promis Neurosciences Shake the Market - StocksToTrade
Promis Neurosciences Shake the Market StocksToTrade
Ally Bridge Group portfolio manager joins ProMIS Neurosciences board - Investing.com
Ally Bridge Group portfolio manager joins ProMIS Neurosciences board Investing.com
Guggenheim Lowers Price Target for ProMIS Neurosciences (PMN) | PMN Stock News - GuruFocus
Guggenheim Lowers Price Target for ProMIS Neurosciences (PMN) | PMN Stock News GuruFocus
ProMIS Neurosciences (NASDAQ:PMN) Will Have To Spend Its Cash Wisely - simplywall.st
ProMIS Neurosciences (NASDAQ:PMN) Will Have To Spend Its Cash Wisely simplywall.st
ProMIS Neurosciences Alights on Path to Novel Alzheimer’s Treatment - StocksToTrade
ProMIS Neurosciences Alights on Path to Novel Alzheimer’s Treatment StocksToTrade
Dozens killed in Central African Republic school stampede - DW
Dozens killed in Central African Republic school stampede DW
ProMIS Neurosciences regains Nasdaq compliance with minimum bid price rule By Investing.com - Inv...
ProMIS Neurosciences regains Nasdaq compliance with minimum bid price rule By Investing.com Investing.com South Africa
ProMIS Neurosciences completes enrollment for Alzheimer’s drug trial By Investing.com - Investing...
ProMIS Neurosciences completes enrollment for Alzheimer’s drug trial By Investing.com Investing.com UK
ProMIS Neurosciences Insiders Still US$234k Away From Original Investment Value - simplywall.st
ProMIS Neurosciences Insiders Still US$234k Away From Original Investment Value simplywall.st
ProMIS Neurosciences launch Phase Ia AβO Alzheimer’s trial - Clinical Trials Arena
ProMIS Neurosciences launch Phase Ia AβO Alzheimer’s trial Clinical Trials Arena
Montauk: Dark ¢loud$ over green promis€ - Financial Mail
Montauk: Dark ¢loud$ over green promis€ Financial Mail
Unease at slow pace of change in Nepal one month on from gen Z protests - The Guardian
Unease at slow pace of change in Nepal one month on from gen Z protests The Guardian
ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights - Glo...
ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights GlobeNewswire
ProMIS reports promising data for selective Alzheimer’s antibody By Investing.com - Investing.com UK
ProMIS reports promising data for selective Alzheimer’s antibody By Investing.com Investing.com UK
Japan’s troubling fiscal laxity - Financial Times
Japan’s troubling fiscal laxity Financial Times
ProMIS Neurosciences shareholders approve share consolidation proposal By Investing.com - Investi...
ProMIS Neurosciences shareholders approve share consolidation proposal By Investing.com Investing.com South Africa
ProMIS reports promising data for selective Alzheimer’s antibody By Investing.com - Investing.com...
ProMIS reports promising data for selective Alzheimer’s antibody By Investing.com Investing.com Canada
‘Promised Sky’ Review: Erige Sehiri Delivers a Keenly Observed Migrant Drama With a Documentarian...
Using an electronic frailty index and patient reported outcomes to predict sarcopenia risk - Nature
Using an electronic frailty index and patient reported outcomes to predict sarcopenia risk Nature
ProMIS Neurosciences Reports Increased R&D Costs and Net Loss - The Globe and Mail
ProMIS Neurosciences Reports Increased R&D Costs and Net Loss The Globe and Mail
ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference - The Manila...
ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference The Manila Times
H.C. Wainwright Maintains ProMIS Neurosciences(PMN.US) With Buy Rating, Cuts Target Price to $18 ...
H.C. Wainwright Maintains ProMIS Neurosciences(PMN.US) With Buy Rating, Cuts Target Price to $18 富途牛牛
ProMIS Neurosciences stock rises after promising Alzheimer’s research data By Investing.com - Inv...
ProMIS Neurosciences stock rises after promising Alzheimer’s research data By Investing.com Investing.com Australia
PMN: HC Wainwright & Co. Reiterates Buy Rating with Unchanged Pr - GuruFocus
PMN: HC Wainwright & Co. Reiterates Buy Rating with Unchanged Pr GuruFocus
ProMIS Neurosciences (PMN): Maxim Group Initiates Coverage with Buy Rating | PMN Stock News - Gur...
ProMIS Neurosciences (PMN): Maxim Group Initiates Coverage with Buy Rating | PMN Stock News GuruFocus
Why ProMIS Neurosciences Inc. (23J0) stock could outperform next year - Quarterly Trade Summary &...
ProMIS Neurosciences Inc. Announces Completion of First Cohort in PRECISE-AD Trial for PMN310 in ...
Will ProMIS Neurosciences Inc. (23J0) stock see valuation expansion - 2025 Volatility Report & Da...
ProMIS reports promising data for selective Alzheimer’s antibody By Investing.com - Investing.com...
ProMIS reports promising data for selective Alzheimer’s antibody By Investing.com Investing.com Nigeria
ProMIS Neurosciences announces 1-for-25 reverse stock split By Investing.com - Investing.com UK
ProMIS Neurosciences announces 1-for-25 reverse stock split By Investing.com Investing.com UK
ProMIS Neurosciences Announces Private Placement Financing | PMN Stock News - GuruFocus
ProMIS Neurosciences Announces Private Placement Financing | PMN Stock News GuruFocus
Trump campaigned as a protector of free speech. Critics say his actions as president threaten it ...
Trump campaigned as a protector of free speech. Critics say his actions as president threaten it AP News
Michael Riconosciuto In ‘The Octopus Murders’: What Is Promis App? - IMDb
Michael Riconosciuto In ‘The Octopus Murders’: What Is Promis App? IMDb
Comparable Real-World Patient-Reported Outcomes Data Across Health Conditions, Settings, and Coun...
Comparable Real-World Patient-Reported Outcomes Data Across Health Conditions, Settings, and Countries: The PROMIS International Collaboration NEJM Catalyst Innovations in Care Delivery
2026 6’3 Promis N’landu (Fort Erie) looking to be a premier PG to watch - Phenom Hoops
2026 6’3 Promis N’landu (Fort Erie) looking to be a premier PG to watch Phenom Hoops
PMN - Promis Neuroscie Latest Stock News & Market Updates - Stock Titan
PMN - Promis Neuroscie Latest Stock News & Market Updates Stock Titan
U.S. State Department Approves $30 Million in Funding for Gaza Humanitarian Foundation - Haaretz
U.S. State Department Approves $30 Million in Funding for Gaza Humanitarian Foundation Haaretz
So feiern Promis in Hessen Weihnachten – CDU-Mann braucht „echten Baum“ - Frankfurter Rundschau
So feiern Promis in Hessen Weihnachten – CDU-Mann braucht „echten Baum“ Frankfurter Rundschau
Orbán vows crackdown on ‘shadow army’ of political opponents - politico.eu
Orbán vows crackdown on ‘shadow army’ of political opponents politico.eu
Trump plans to use emergency powers to fast-track generation co-located with AI - Utility Dive
Trump plans to use emergency powers to fast-track generation co-located with AI Utility Dive
Germany's CDU vows to make AfD 'as small as possible again' - DW
Germany's CDU vows to make AfD 'as small as possible again' DW
ProMIS Neurosciences announces 1-for-25 reverse stock split By Investing.com - Investing.com Canada
ProMIS Neurosciences announces 1-for-25 reverse stock split By Investing.com Investing.com Canada
Hundreds reported killed in sectarian violence in Syria’s Alawite heartland - The Washington Post
Hundreds reported killed in sectarian violence in Syria’s Alawite heartland The Washington Post